These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6382056)

  • 21. [Hypertension treatment in a health resort].
    Brommer W; Ciric D
    Med Welt; 1981 Apr; 32(14):473-5. PubMed ID: 7219161
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antihypertensive combination-therapy with inositol nicotinate in essential hypertension].
    Krämer KD; Ghabussi P; Hochrein H
    Med Welt; 1977 Jul; 28(27):1198-1201. PubMed ID: 329049
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical and fundamental study of guanabenz in hypertensive patients with renal failure].
    Nishio S; Hayashi S; Yoshihara H
    Hinyokika Kiyo; 1988 Jun; 34(6):1083-9. PubMed ID: 3223454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy and tolerance of guanabenz in patients with associated chronic cardio-circulatory, respiratory, infectious and metabolic diseases].
    Argentieri M; Mazzanti A
    Minerva Cardioangiol; 1984 May; 32(5):291-8. PubMed ID: 6472629
    [No Abstract]   [Full Text] [Related]  

  • 25. Further observations on a new antihypertensive Vatensol (Compound 1029).
    Srivastava BN; Vyas GP; Tiwari AK; Tapa RS; Nema HS
    Indian Heart J; 1967 Oct; 19(4):329-35. PubMed ID: 4870899
    [No Abstract]   [Full Text] [Related]  

  • 26. [Guanabenz in hypertension in the aged].
    Storti R; Patola R
    Minerva Cardioangiol; 1984 May; 32(5):299-303. PubMed ID: 6472630
    [No Abstract]   [Full Text] [Related]  

  • 27. [Controlled study of the anti-hypertensive effects of indapamide, metoprolol and their combination in patients with essential arterial hypertension].
    Novo S; Licata G; Pinto A; Davì G; Pepe S; Di Vitale P; Mannino V; Strano A
    Cardiologia; 1982; 27(8):765-88. PubMed ID: 6765266
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of guanabenz on plasma renin and aldosterone and on sodium balance in hypertensive patients].
    Bevilacqua M; Meroni R; Scorza D; Vago T; Norbiato G
    Minerva Cardioangiol; 1984 May; 32(5):267-71. PubMed ID: 6382053
    [No Abstract]   [Full Text] [Related]  

  • 29. [Controlled study of antihypertensive effects of indapamide and metoprolol and their combination in patients with essential arterial hypertension].
    Novo S; Licata G; Pinto A; Davì G; Pepe S; Di Vitale P; Mannino V; Strano A
    Cardiologia; 1982; 27(8):765-88. PubMed ID: 6765445
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antihypertensive action and renal effects of guanabenz].
    Pessina AC; Milani L; Gatta A; Hlede M; Amodio P; Palatini P; Frigo A; Semplicini A; Casiglia E; Merkel C
    Minerva Cardioangiol; 1984 May; 32(5):285-90. PubMed ID: 6472628
    [No Abstract]   [Full Text] [Related]  

  • 31. Guanabenz in essential hypertension.
    McMahon FG; Ryan JR; Jain AK; Vargas R; Vanov SK
    Clin Pharmacol Ther; 1977 Mar; 21(3):272-7. PubMed ID: 319938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanism of hypotensive action of a diuretic, mefruside, based on the pressure-natriuresis relationship].
    Saito F; Kimura G; Shimozaki Y; Fujii T; Ishii T; Yoshida K; Abe H; Kawamura M; Deguchi F; Kawano Y
    Nihon Jinzo Gakkai Shi; 1987 Apr; 29(4):461-7. PubMed ID: 3656703
    [No Abstract]   [Full Text] [Related]  

  • 33. [Guanfacine in primary arterial hypertension: a long-term open clinical study].
    Román O; Valenzuela MA; Salazar R
    Rev Med Chil; 1982 Dec; 110(12):1179-84. PubMed ID: 6764015
    [No Abstract]   [Full Text] [Related]  

  • 34. Haemodynamic parameters in hypertensive patients treated with a diuretic and with a diuretic in combination with a beta-blocker.
    Harvald B; Fabricius J; Thomsen A
    Acta Med Scand Suppl; 1979; 625():22-5. PubMed ID: 373396
    [No Abstract]   [Full Text] [Related]  

  • 35. [The effect of beta-receptor antagonists and diuretics and their combination on blood pressure and pressure-rate product during ergometric work in hypertensive patients (author's transl)].
    Franz IW
    Z Kardiol; 1982 Jan; 71(2):129-37. PubMed ID: 7072313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Blood pressure and serum potassium during 6 months of mefruside treatment].
    Jagenburg R; Landahl S; Steen B
    Lakartidningen; 1977 Jul; 74(27-28):2509-11. PubMed ID: 875560
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antihypertensive activity of a new molecule, 2,6-dichloro-benzylidene aminoguanidine acetate].
    Chiummo R
    Minerva Med; 1975 Dec; 66(84):4546-50. PubMed ID: 1202408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Double-blind controlled study of the therapeutic effectiveness and tolerance of the guabenxan-bemetizid combination as compared with guanethidine-hydrochlorothiazide in arterial hypertension in the aged].
    Silvestrini C; Maini C; Marchesi M; Mueller G
    G Clin Med; 1982 Apr; 63(4):270-8. PubMed ID: 6751915
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of guanabenz, alpha 2 central agonist, on the activity of the sympathetic nervous system during dynamic and isometric physical exercise].
    Fariello R; Agabiti-Rosei E; Alicandri C; Romanelli G; Muiesan G; Renzetti I
    Minerva Cardioangiol; 1984 May; 32(5):273-9. PubMed ID: 6382054
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term therapy of hypertension with guanabenz.
    Walker BR; Deitch MW; Schneider BE; Hare LE; Gold JA
    Clin Ther; 1981; 4(3):217-28. PubMed ID: 7307037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.